News
FDA does a 180, suspending use of Valneva's chikungunya vaccine
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the shot in the United States. | Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq,
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
The U.S. Food & Drug Administration (FDA) has announced a recall on a limited lot of Blue Bell Ice Cream due to the presence ...
The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full ...
As the HHS and FDA leadership continues to look for ways to boost transparency and reshape the United States' healthcare ...
The FDA has broadened the indication for evolocumab (Repatha; Amgen) to include adults at increased risk of major adverse ...
The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...
Verywell Health on MSN4h
Wegovy Is Now the Second FDA-Approved Treatment for MASH Fibrosis
Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...
The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...
The FDA has announced a recall of nearly 2,000 cases of 7Up Zero Sugar Tropical soda due to a labeling error. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback